title: [Special issues related to the treatment of acute leukemias in women].
abstract: The treatment of acute leukemia is usually similar in women and men. The outcome is also generally the same. However, diagnosis in women poses additional challenges in clinical practice such as leukemia following breast or ovarian cancers, prevention of abnormal uterine bleeding in premenopausal females, treatment during pregnancy related-problems in long-term survivors. All these special issues are addressed in this review of the literature.
authors.affiliation: Hôpital Edouard-Herriot, Service hématologie, 5, place d'Arsonval, 69437 Lyon, France. xavier.thomas@chu-lyon.fr
authors.forename: X
authors.initials: X
authors.lastname: Thomas
authors.forename: G
authors.initials: G
authors.lastname: Cannas
authors.forename: Y
authors.initials: Y
authors.lastname: Chelghoum
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000628:therapy; D005260:Female; D005298:Fertility / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000628:therapy; D010053:Ovary / Q000187:drug effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000209:etiology / Q000628:therapy; D011628:Puberty, Delayed / Q000139:chemically induced; D012737:Sex Factors; D014594:Uterine Neoplasms / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents